Application 020369
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CILOXAN | CIPROFLOXACIN HYDROCHLORIDE | OINTMENT;OPHTHALMIC | EQ 0.3% BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0065-0654 | CILOXAN | ciprofloxacin hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0654 | CILOXAN | ciprofloxacin hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0654 | CILOXAN | ciprofloxacin hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0654 | CILOXAN | ciprofloxacin hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0654 | CILOXAN | ciprofloxacin hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0078-0841 | CILOXAN | ciprofloxacin hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0841 | CILOXAN | ciprofloxacin hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 47269 | SUPPL | 2017-02-21 |
| 47268 | SUPPL | 2017-02-21 |
| 34564 | SUPPL | 2004-07-21 |
| 24856 | SUPPL | 2004-07-21 |
| 12494 | SUPPL | 2004-07-21 |
| 2402 | SUPPL | 2004-07-21 |
| 34563 | SUPPL | 2003-10-07 |
| 12493 | SUPPL | 2003-10-07 |
| 24855 | SUPPL | 2003-08-28 |
| 2401 | SUPPL | 2003-08-28 |
| 41303 | ORIG | 2003-05-15 |
| 12492 | ORIG | 1998-03-30 |
| 2400 | ORIG | 1998-03-30 |